Report Overview
Epidermal Growth Factor (EGF) is a growth factor that stimulates cell growth, proliferation, and differentiation by binding to its receptor EGFR. Human EGF is a 6045-Da protein with 53 amino acid residues and three intramolecular disulfide bonds EGF results in cellular proliferation, differentiation, and survival.
This report provides a deep insight into the global Cosmetic Grade EGF market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
www.reallygreatsite.com
Market Share
The global Cosmetic Grade EGF market size was estimated at USD 645 million in 2023 and is projected to reach USD 1289.36 million by 2032, exhibiting a CAGR of 8.00% during the forecast period.
North America Cosmetic Grade EGF market size was estimated at USD 191.91 million in 2023, at a CAGR of 6.86% during the forecast period of 2025 through 2032.
Key Company
• BIOEFFECT
• LipoTrue
• Skin Actives
• BIO-FD&C
• Spec Chem
• Caregen
Market Segmentation
• Liquid
• Powder
By Application
• EGF Cream
• EGF Mask
• EGF Lotion
Geographic Segmentation
•North America: USA, Canada, Mexico
•Europe: Germany, UK, France, Russia, Italy, Rest of Europe
•Asia-Pacific: China, Japan, South Korea, India, SoutheastAsia, Rest ofAsia-Pacific
•South America: Brazil, Argentina, Colombia, Rest of SouthAmerica
•Middle East and Africa: Saudi Arabia, UAE, Egypt, Nigeria, SouthAfrica, Rest of MEA
